These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 19736615

  • 1. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death.
    Erez O, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Kusanovic JP, Kim CJ, Chaiworapongsa T, Hoppensteadt D, Fareed J, Than NG, Nhan-Chang CL, Yeo L, Pacora P, Mazor M, Hassan SS, Mittal P, Romero R.
    J Matern Fetal Neonatal Med; 2009 Aug; 22(8):672-87. PubMed ID: 19736615
    [Abstract] [Full Text] [Related]

  • 2. Coagulation and fibrinolysis in amniotic fluid: physiology and observations on amniotic fluid embolism, preterm fetal membrane rupture, and pre-eclampsia.
    Uszyński M, Uszyński W.
    Semin Thromb Hemost; 2011 Mar; 37(2):165-74. PubMed ID: 21370219
    [Abstract] [Full Text] [Related]

  • 3. A link between a hemostatic disorder and preterm PROM: a role for tissue factor and tissue factor pathway inhibitor.
    Erez O, Espinoza J, Chaiworapongsa T, Gotsch F, Kusanovic JP, Than NG, Mazaki-Tovi S, Vaisbuch E, Papp Z, Yoon BH, Han YM, Hoppensteadt D, Fareed J, Hassan SS, Romero R.
    J Matern Fetal Neonatal Med; 2008 Oct; 21(10):732-44. PubMed ID: 19012190
    [Abstract] [Full Text] [Related]

  • 4. High tissue factor activity and low tissue factor pathway inhibitor concentrations in patients with preterm labor.
    Erez O, Romero R, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Chaiworapongsa T, Gotsch F, Fareed J, Hoppensteadt D, Than NG, Yoon BH, Edwin S, Dong Z, Espinoza J, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2010 Jan; 23(1):23-33. PubMed ID: 19883261
    [Abstract] [Full Text] [Related]

  • 5. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Jan; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 6. Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.
    Erez O, Romero R, Vaisbuch E, Than NG, Kusanovic JP, Mazaki-Tovi S, Gotsch F, Mittal P, Dong Z, Chaiworapongsa T, Kim CJ, Nhan-Chang CL, Kim SK, Yeo L, Mazor M, Hassan SS.
    J Matern Fetal Neonatal Med; 2018 Jun; 31(12):1568-1577. PubMed ID: 28521572
    [Abstract] [Full Text] [Related]

  • 7. Changes in amniotic fluid concentration of thrombin-antithrombin III complexes in patients with preterm labor: evidence of an increased thrombin generation.
    Erez O, Romer R, Vaisbuch E, Chaiworapongsa T, Kusanovic JP, Mazaki-Tovi S, Gotsch F, Gomez R, Maymon E, Pacora P, Edwin SS, Kim CJ, Than NG, Mittal P, Yeo L, Dong Z, Yoon BH, Hassan SS, Mazor M.
    J Matern Fetal Neonatal Med; 2009 Nov; 22(11):971-82. PubMed ID: 19900035
    [Abstract] [Full Text] [Related]

  • 8. [Thrombin markers in pregnant women: measurements of prothrombin fragments F 1+2 and thrombin-antithrombin III complexes (TAT) in the cord blood, the mother's blood and in amniotic fluid].
    Uszyński W, Uszyński M, Zekanowska E.
    Ginekol Pol; 2004 Aug; 75(8):595-602. PubMed ID: 15517782
    [Abstract] [Full Text] [Related]

  • 9. Activation of coagulation in amniotic fluid during normal human pregnancy.
    Sarig G, Klil-Drori AJ, Chap-Marshak D, Brenner B, Drugan A.
    Thromb Res; 2011 Nov; 128(5):490-5. PubMed ID: 21504838
    [Abstract] [Full Text] [Related]

  • 10. Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.
    Chaiworapongsa T, Kusanovic JP, Savasan ZA, Mazaki-Tovi S, Kim SK, Vaisbuch E, Tarca AL, Mittal P, Ogge G, Madan I, Dong Z, Yeo L, Hassan SS, Romero R.
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):960-72. PubMed ID: 20158395
    [Abstract] [Full Text] [Related]

  • 11. New observations on procoagulant properties of amniotic fluid: microparticles (MPs) and tissue factor-bearing MPs (MPs-TF), comparison with maternal blood plasma.
    Uszyński W, Zekanowska E, Uszyński M, Zyliński A, Kuczyński J.
    Thromb Res; 2013 Sep; 132(6):757-60. PubMed ID: 24157083
    [Abstract] [Full Text] [Related]

  • 12. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
    Park CW, Park JS, Shim SS, Jun JK, Yoon BH, Romero R.
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
    [Abstract] [Full Text] [Related]

  • 13. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M, Zekanowska E, Uszyński W, Kuczyński J, Zyliński A.
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [Abstract] [Full Text] [Related]

  • 14. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.
    Xiong Y, Zhou SF, Zhou R, Yang D, Xu ZF, Lou YT, Guo QS, Hu R, Peng T, Ma D, Li XT.
    Hypertens Pregnancy; 2011 Sep; 30(3):347-58. PubMed ID: 21174589
    [Abstract] [Full Text] [Related]

  • 15. Prospective investigation of second-trimester thrombin activation and preterm birth.
    Vidaeff AC, Monga M, Saade G, Bishop K, Ramin SM.
    Am J Obstet Gynecol; 2012 Apr; 206(4):333.e1-6. PubMed ID: 22464077
    [Abstract] [Full Text] [Related]

  • 16. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 17. Thrombin-antithrombin III complexes and antithrombin III in amniotic fluid.
    Uszyński M, Kielkowski A, Uszyński W, Zekanowska E.
    Gynecol Obstet Invest; 1997 Mar; 43(1):29-33. PubMed ID: 9015695
    [Abstract] [Full Text] [Related]

  • 18. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism.
    Uszyński M, Zekanowska E, Uszyński W, Kuczyński J.
    Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):163-6. PubMed ID: 11301162
    [Abstract] [Full Text] [Related]

  • 19. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B, Barbay V, Borg JY, Le Cam-Duchez V.
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [Abstract] [Full Text] [Related]

  • 20. Is thrombin activation predictive of subsequent preterm delivery?
    Vidaeff AC, Monga M, Ramin SM, Saade G, Sangi-Haghpeykar H.
    Am J Obstet Gynecol; 2013 Apr; 208(4):306.e1-7. PubMed ID: 23531327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.